SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
AstraZeneca PLC Release: BRILINTA (ticagrelor) Launches “Complete the Course” — a Creative Education Program for Patients With ACS, Including “Access My BRILINTA” Support Service Focused on Continuity of Care